US4487934A
(en)
|
1980-06-06 |
1984-12-11 |
Hoechst-Roussel Pharmaceuticals Inc. |
Method of preparing poly-substituted acylbenzenes
|
US4501729A
(en)
|
1982-12-13 |
1985-02-26 |
Research Corporation |
Aerosolized amiloride treatment of retained pulmonary secretions
|
DE3326472A1
(de)
|
1983-07-22 |
1985-02-14 |
Hoechst Ag, 6230 Frankfurt |
Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus
|
EP0158913B1
(en)
|
1984-04-06 |
1988-07-20 |
ZAMBON S.p.A. |
Process for the preparation of optically active alpha-arylalkanoic acids and intermediates thereof
|
US5658772A
(en)
|
1989-12-22 |
1997-08-19 |
E. I. Du Pont De Nemours And Company |
Site-specific recombination of DNA in plant cells
|
AU654979B2
(en)
|
1990-10-05 |
1994-12-01 |
University Of North Carolina At Chapel Hill, The |
Method of administering amiloride
|
US5173414A
(en)
|
1990-10-30 |
1992-12-22 |
Applied Immune Sciences, Inc. |
Production of recombinant adeno-associated virus vectors
|
US5292498A
(en)
|
1991-06-19 |
1994-03-08 |
The University Of North Carolina At Chapel Hill |
Method of treating lung disease with uridine triphosphates
|
US6083713A
(en)
|
1992-08-31 |
2000-07-04 |
Bristol-Myers Squibb Company |
Cloning and expression of βAPP-C100 receptor (C100-R)
|
US5478745A
(en)
|
1992-12-04 |
1995-12-26 |
University Of Pittsburgh |
Recombinant viral vector system
|
US5869305A
(en)
|
1992-12-04 |
1999-02-09 |
The University Of Pittsburgh |
Recombinant viral vector system
|
US5686436A
(en)
|
1993-05-13 |
1997-11-11 |
Hiv Diagnostics, Inc. |
Multi-faceted method to repress reproduction of latent viruses in humans and animals
|
US5512269A
(en)
|
1993-06-09 |
1996-04-30 |
Burroughs Wellcome, Co. |
Method of treating retained pulmonary secretions
|
US5498531A
(en)
|
1993-09-10 |
1996-03-12 |
President And Fellows Of Harvard College |
Intron-mediated recombinant techniques and reagents
|
DE69433592T2
(de)
|
1993-11-09 |
2005-02-10 |
Targeted Genetics Corp., Seattle |
Die erzielung hoher titer des rekombinanten aav-vektors
|
US5750398A
(en)
|
1993-11-30 |
1998-05-12 |
David C. Johnson |
Vector, element and method for inhibiting immune recognition
|
AU1846695A
(en)
|
1994-02-16 |
1995-09-04 |
Idun Pharmaceuticals |
Methods for controlling free radical generation by inflammatory cells
|
US5604090A
(en)
|
1994-06-06 |
1997-02-18 |
Fred Hutchinson Cancer Research Center |
Method for increasing transduction of cells by adeno-associated virus vectors
|
US5656256A
(en)
|
1994-12-14 |
1997-08-12 |
The University Of North Carolina At Chapel Hill |
Methods of treating lung disease by an aerosol containing benzamil or phenamil
|
US5843742A
(en)
|
1994-12-16 |
1998-12-01 |
Avigen Incorporated |
Adeno-associated derived vector systems for gene delivery and integration into target cells
|
US6281010B1
(en)
|
1995-06-05 |
2001-08-28 |
The Trustees Of The University Of Pennsylvania |
Adenovirus gene therapy vehicle and cell line
|
US5635160A
(en)
|
1995-06-07 |
1997-06-03 |
The University Of North Carolina At Chapel Hill |
Dinucleotides useful for the treatment of cystic fibrosis and for hydrating mucus secretions
|
US5853716A
(en)
|
1995-07-28 |
1998-12-29 |
Yale University |
Genetically engineered chimeric viruses for the treatment of diseases associated with viral transactivators
|
US5628984A
(en)
|
1995-07-31 |
1997-05-13 |
University Of North Carolina At Chapel Hill |
Method of detecting lung disease
|
WO1997007128A1
(en)
|
1995-08-21 |
1997-02-27 |
Duke University |
A method to increase the density of antigen on antigen presenting cells
|
US5801030A
(en)
|
1995-09-01 |
1998-09-01 |
Genvec, Inc. |
Methods and vectors for site-specific recombination
|
WO1997009997A1
(en)
|
1995-09-12 |
1997-03-20 |
Genentech, Inc. |
Cystic fibrosis therapy
|
EP0883344B2
(en)
|
1995-12-15 |
2010-06-09 |
VIRxSYS Corporation |
Therapeutic molecules generated by trans-splicing
|
US6083702A
(en)
|
1995-12-15 |
2000-07-04 |
Intronn Holdings Llc |
Methods and compositions for use in spliceosome mediated RNA trans-splicing
|
DE19605279A1
(de)
|
1996-02-13 |
1997-08-14 |
Hoechst Ag |
Zielzellspezifische Vektoren für die Einschleusung von Genen in Zellen, Arzneimittel enthaltend derartige Vektoren und deren Verwendung
|
US6420347B1
(en)
|
1997-03-27 |
2002-07-16 |
Inspire Pharmaceuticals, Inc. |
Method of treating ciliary dyskinesia with uridine triphosphates and related compounds
|
US5939460A
(en)
|
1996-07-08 |
1999-08-17 |
Idun Pharmaceuticals, Inc. |
Method of inhibiting NADPH oxidase
|
JP2001500376A
(ja)
|
1996-09-06 |
2001-01-16 |
カイロン コーポレイション |
組換えaavベクターを使用する治療分子の肝臓特異的送達のための方法および組成物
|
IL128779A0
(en)
|
1996-09-06 |
2000-01-31 |
Univ Pennsylvania |
Method for recombinant adeno-associated virus-directed gene therapy
|
US6110744A
(en)
|
1996-11-13 |
2000-08-29 |
Board Of Regents, The University Of Texas System |
Diminishing viral gene expression by promoter replacement
|
WO1998024479A1
(en)
|
1996-12-02 |
1998-06-11 |
Cell Genesys, Inc. |
Adeno-associated viral vector-mediated delivery of dna to cells of the liver
|
US6153436A
(en)
|
1997-01-10 |
2000-11-28 |
The Board Of Trustees Of The University Of Arkansas |
Method of gene delivery using wildtype adeno associated viral (AAV) vectors with insertions
|
US6287569B1
(en)
|
1997-04-10 |
2001-09-11 |
The Regents Of The University Of California |
Vaccines with enhanced intracellular processing
|
FR2763845B1
(fr)
|
1997-05-30 |
2003-04-18 |
Centre Nat Rech Scient |
Produits anti-cancereux pour le traitement de la mucoviscidose
|
US6156303A
(en)
|
1997-06-11 |
2000-12-05 |
University Of Washington |
Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
|
US6037177A
(en)
|
1997-08-08 |
2000-03-14 |
Cell Genesys, Inc. |
Method for increasing the efficiency of recombinant AAV production
|
CN1268056A
(zh)
|
1997-08-29 |
2000-09-27 |
查珀尔希尔北卡罗来纳大学 |
尿苷5’-二磷酸酯及其类似物在治疗肺疾病中的应用
|
WO1999018227A1
(en)
|
1997-10-08 |
1999-04-15 |
Advanced Research And Technology Institute |
Chimeric parvovirus-based recombinant vector system that specifically targets the erythroid lineage
|
US6642051B1
(en)
|
1997-10-21 |
2003-11-04 |
Targeted Genetics Corporation |
Amplifiable adeno-associated virus(AAV) packaging cassettes for the production of recombinant AAV vectors
|
AU756827B2
(en)
|
1997-10-21 |
2003-01-23 |
Targeted Genetics Corporation |
Transcriptionally-activated AAV inverted terminal repeats (ITRs) for use with recombinant AAV vectors
|
JP2001526900A
(ja)
|
1997-12-23 |
2001-12-25 |
イントロヘーネ ベスローテン フェンノートシャップ |
標的細胞の染色体dnaへの外来遺伝子情報の組み込みに有用な、アデノ随伴ウイルスおよびアデノウイルスのキメラ組換えウイルス
|
US6436392B1
(en)
|
1998-05-20 |
2002-08-20 |
University Of Iowa Research Foundation |
Adeno-associated virus vectors
|
WO1999061012A2
(en)
|
1998-05-22 |
1999-12-02 |
Inspire Pharmaceuticals, Inc. |
Therapeutic dinucleotide and derivatives
|
ES2313784T3
(es)
|
1998-05-28 |
2009-03-01 |
The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services |
Vector aav5 y usos del mismo.
|
IL128017A0
(en)
|
1998-07-22 |
1999-11-30 |
Technion Res & Dev Foundation |
Method for detecting protein-protein interactions and a kit therefor
|
US6290951B1
(en)
|
1998-08-01 |
2001-09-18 |
Alfacell Corporation |
Alteration of the cell cycle in vivo, and particularly for inducing apoptosis of tumor cells
|
ES2140354B1
(es)
|
1998-08-03 |
2000-11-01 |
S A L V A T Lab Sa |
Imidazo (1,2a) azinas sustituidas como inhibidores selectivos de la cox-2.
|
ATE347880T1
(de)
|
1998-10-20 |
2007-01-15 |
Univ North Carolina |
Methoden zum befeuchten der nasenschleimhaut
|
US6200560B1
(en)
|
1998-10-20 |
2001-03-13 |
Avigen, Inc. |
Adeno-associated virus vectors for expression of factor VIII by target cells
|
US6221349B1
(en)
|
1998-10-20 |
2001-04-24 |
Avigen, Inc. |
Adeno-associated vectors for expression of factor VIII by target cells
|
US6491907B1
(en)
|
1998-11-10 |
2002-12-10 |
The University Of North Carolina At Chapel Hill |
Recombinant parvovirus vectors and method of making
|
EP1131425A2
(en)
|
1998-11-18 |
2001-09-12 |
Incyte Pharmaceuticals, Inc. |
Inflammation-associated genes
|
US6855549B1
(en)
|
1998-11-23 |
2005-02-15 |
The University Of Iowa Research Foundation |
Methods and compositions for increasing the infectivity of gene transfer vectors
|
US6926911B1
(en)
|
1998-12-22 |
2005-08-09 |
The University Of North Carolina At Chapel Hill |
Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs
|
US6512102B1
(en)
|
1998-12-31 |
2003-01-28 |
Chiron Corporation |
Compositions and methods of diagnosis and treatment using casein kinase I
|
WO2000047230A1
(fr)
|
1999-02-10 |
2000-08-17 |
The Kitasato Institute |
Potentialisateurs d'agent anticancereux
|
US6306663B1
(en)
|
1999-02-12 |
2001-10-23 |
Proteinex, Inc. |
Controlling protein levels in eucaryotic organisms
|
US6893865B1
(en)
|
1999-04-28 |
2005-05-17 |
Targeted Genetics Corporation |
Methods, compositions, and cells for encapsidating recombinant vectors in AAV particles
|
CA2270795A1
(en)
|
1999-05-05 |
2000-11-05 |
Gestilab Inc. |
Neuroprotective compositions and uses thereof
|
EP1190249A2
(en)
|
1999-06-08 |
2002-03-27 |
University Of Iowa Research Foundation |
Compounds and methods to enhance raav transduction
|
US7122335B1
(en)
|
1999-06-08 |
2006-10-17 |
University Of Iowa Research Foundation |
Compounds and methods to enhance rAAV transduction
|
US6475509B1
(en)
|
1999-07-19 |
2002-11-05 |
The University Of North Carolina At Chapel Hill |
Covalent conjugates of sodium channel blockers and active compounds
|
US6475537B1
(en)
|
2000-07-27 |
2002-11-05 |
Rhodia Inc. |
Hops acid antibacterial compositions
|
EP2369002A1
(en)
|
1999-08-09 |
2011-09-28 |
Targeted Genetics Corporation |
Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms intrastrand base pairs
|
US6416759B1
(en)
|
1999-09-30 |
2002-07-09 |
The Regents Of The University Of California |
Antiproliferative Sgk reagents and methods
|
US7241447B1
(en)
|
1999-10-07 |
2007-07-10 |
University Of Iowa Research Foundation |
Adeno-associated virus vectors and uses thereof
|
EP1224313A1
(en)
|
1999-10-07 |
2002-07-24 |
University of Iowa Research Foundation |
Adeno-associated viruses and uses thereof
|
AU784420B2
(en)
|
1999-10-07 |
2006-03-30 |
University Of Iowa Research Foundation, The |
Adeno-associated viruses and uses thereof
|
WO2001027303A1
(en)
|
1999-10-12 |
2001-04-19 |
The University Of North Carolina At Chapel Hill |
Adeno-associated virus vectors encoding factor viii and methods of using the same
|
AU7895700A
(en)
|
1999-10-15 |
2001-04-30 |
Dalhousie University |
Method and vector for producing and transferring trans-spliced peptides
|
US20020132770A1
(en)
|
1999-10-27 |
2002-09-19 |
Caplan Michael T. |
Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
|
AU2001240018A1
(en)
|
2000-03-03 |
2001-09-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Adeno-associated viral compositions and methods
|
WO2001068888A2
(en)
|
2000-03-14 |
2001-09-20 |
Neurologix, Inc. |
Production of chimeric capsid vectors
|
CA2302627A1
(en)
|
2000-03-23 |
2001-09-23 |
Rashmi Kothary |
Constructs comprising the enac promoter sequence and a reporter gene for screening pharmaceuticals
|
US20020076754A1
(en)
|
2000-04-20 |
2002-06-20 |
Liangwu Sun |
Overcoming AAV vector size limitation through viral DNA hetero-dimerization
|
CA2406743A1
(en)
|
2000-04-28 |
2001-11-08 |
The Trustees Of The University Of Pennsylvania |
Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids
|
AU2001269723B9
(en)
|
2000-06-01 |
2006-11-16 |
University Of North Carolina At Chapel Hill |
Duplexed parvovirus vectors
|
US20020095135A1
(en)
|
2000-06-19 |
2002-07-18 |
David Meeker |
Combination enzyme replacement, gene therapy and small molecule therapy for lysosomal storage diseases
|
US6492429B1
(en)
|
2000-07-10 |
2002-12-10 |
N.V. Nutricia |
Composition for the treatment of osteoarthritis
|
US6485950B1
(en)
|
2000-07-14 |
2002-11-26 |
Council Of Scientific And Industrial Research |
Isozyme of autoclavable superoxide dismutase (SOD), a process for the identification and extraction of the SOD in cosmetic, food and pharmaceutical compositions
|
US6329181B1
(en)
|
2000-08-07 |
2001-12-11 |
Neurologix, Inc. |
Helper functions for recombinant vector production
|
AU2001283278A1
(en)
|
2000-08-10 |
2002-02-25 |
Neurologix, Inc. |
Replication competent aav helper functions
|
US20020128203A1
(en)
|
2000-09-20 |
2002-09-12 |
Laurent Schild |
Methods of identifying inhibitory compounds and uses thereof
|
ATE270544T1
(de)
|
2000-09-22 |
2004-07-15 |
Galephar M F |
Halbfeste arzneizubereitung enthaltend isotretinoin
|
US20020115619A1
(en)
|
2000-10-04 |
2002-08-22 |
Rubenstein Ronald C. |
Compositions and methods for treatment of cystic fibrosis
|
AU2002251844A1
(en)
|
2001-02-02 |
2002-10-03 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of colon cancer
|
US20030013137A1
(en)
|
2001-03-13 |
2003-01-16 |
Barak Larry S. |
Automated methods of detecting receptor activity
|
CA2482124C
(en)
|
2001-04-19 |
2008-10-07 |
Uab Research Foundation |
Methods of treatment using an epithelial sodium channel blocker and an inhibitor of the mineralocorticoid receptor
|
WO2002087306A2
(en)
|
2001-05-01 |
2002-11-07 |
Senomyx, Inc. |
High throughput cell-based assay for monitoring sodium channel activity and discovery of salty taste modulating compounds
|
US20030003583A1
(en)
|
2001-06-08 |
2003-01-02 |
Raphael Hirsch |
Regulation of transgene expression following AAV transduction
|
JP2004534955A
(ja)
|
2001-07-12 |
2004-11-18 |
エクセリクシス・インコーポレイテッド |
p21経路のモディファイヤーとしてのHADHsおよび使用方法
|
US20030103939A1
(en)
|
2001-07-13 |
2003-06-05 |
Engelhardt John F. |
Pseudotyped adeno-associated viruses and uses thereof
|
US8241622B2
(en)
|
2001-07-13 |
2012-08-14 |
University Of Iowa Research Foundation |
Adeno-associated virus vectors with intravector heterologous terminal palindromic sequences
|
US20030108920A1
(en)
|
2001-09-07 |
2003-06-12 |
Wei Zhang |
Tumor suppressor-like proteins that bind IGFBP2
|
JP2003201255A
(ja)
|
2001-11-05 |
2003-07-18 |
Otsuka Pharmaceut Factory Inc |
アルツハイマー病予防および治療剤
|
US6723551B2
(en)
|
2001-11-09 |
2004-04-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Production of adeno-associated virus in insect cells
|
CA2467959C
(en)
|
2001-11-09 |
2009-03-10 |
Robert M. Kotin |
Production of adeno-associated virus in insect cells
|
AU2002367943A1
(en)
|
2001-12-18 |
2003-12-22 |
University Of North Carolina At Chapel Hill |
Improved reagents and methods for producing parvoviruses
|
EP1478655A4
(en)
|
2001-12-31 |
2006-05-10 |
Algos Therapeutics Inc |
METHODS AND SUBSTANCES FOR ENAC-BETA MODULATION
|
AU2003224549A1
(en)
|
2002-04-17 |
2003-10-27 |
Biovitrum Ab |
Nad)p)h oxidase inhibitors for increased glucose uptake and treatment of type ii diabetes
|
PT1509618E
(pt)
|
2002-05-13 |
2008-12-02 |
Arexis Ab |
Condições autoimunes e deficiências de nadph-oxidase
|
EP1534990B1
(en)
|
2002-07-23 |
2006-10-25 |
Medi-Physics, Inc. |
Automated dynamic pressure-responsive hyperpolarized gas dispensing systems, and associated methods and computer program products
|
WO2004047772A2
(en)
|
2002-11-26 |
2004-06-10 |
Florida Atlantic University |
Catalytic antioxidants and methods of use
|
KR100522188B1
(ko)
|
2003-01-20 |
2005-10-18 |
주식회사 뉴로테크 |
뉴로트로핀에 의해 유도되는 세포괴사 억제 방법
|
JP2006521825A
(ja)
|
2003-03-31 |
2006-09-28 |
ユニバーシテイ・オブ・アイオワ・リサーチ・フアウンデーシヨン |
rAAV導入を高めるための化合物および方法
|
EP1486567A1
(en)
|
2003-06-11 |
2004-12-15 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Improved adeno-associated virus (AAV) vector for gene therapy
|
HUE054046T2
(hu)
|
2003-06-19 |
2021-08-30 |
Genzyme Corp |
Csökkentett immunreaktivitású AAV virionok és alkalmazásaik
|
WO2005049850A2
(en)
|
2003-11-14 |
2005-06-02 |
University Of Washington |
Compositions and methods for systemic nucleic acid sequence delivery
|
WO2005056762A2
(en)
|
2003-12-05 |
2005-06-23 |
University Of Iowa Research Foundation |
Truncated cmv promoters and vectors containing same
|
US7067659B2
(en)
|
2004-04-23 |
2006-06-27 |
Duke University |
Reactive oxygen generating enzyme inhibitor with nitric oxide bioactivity and uses thereof
|
WO2005116224A2
(en)
|
2004-05-18 |
2005-12-08 |
Children's Memorial Hospital |
Tetracycline-regulated adeno-associated viral (aav) vectors for gene delivery to the nervous system
|
EP1602926A1
(en)
|
2004-06-04 |
2005-12-07 |
University of Geneva |
Novel means and methods for the treatment of hearing loss and phantom hearing
|
US20060002913A1
(en)
|
2004-06-22 |
2006-01-05 |
Gehlsen Kurt R |
Use of histamine and related compounds to treat disorders affecting muscle function
|
WO2006116503A2
(en)
|
2005-04-26 |
2006-11-02 |
Irm Llc |
Methods and compositions for modulating wnt signaling pathway
|
US8110350B2
(en)
|
2005-11-17 |
2012-02-07 |
Karolinska Institutet Innovations Ab |
Human Bocavirus and methods of diagnosis and treatment
|
US20070265350A1
(en)
|
2005-12-30 |
2007-11-15 |
University Of Iowa Research Foundation |
Method of identifying compounds useful to treat neuronal degenerative diseases
|
US20090017062A1
(en)
|
2006-04-28 |
2009-01-15 |
Iowa Research Foundation Iowa Centers For Enterpri |
Methods and compounds to alter virus infection
|
US20100113343A1
(en)
|
2006-09-22 |
2010-05-06 |
Julia Skokowa |
Methods involving lef-1 regulation and use of lef-1 or compounds altering lef-1 signalling for treating or preventing diseases
|
WO2008133904A1
(en)
|
2007-04-23 |
2008-11-06 |
Stowers Institute For Medical Research |
Methods and compositions for stem cell self-renewal
|
EP2184073A4
(en)
|
2007-08-24 |
2010-10-20 |
Kyowa Hakko Kirin Co Ltd |
AGAINST PROTEASE HEMMER RESISTANT CANCER THERAPEUTICS
|
US20090241206A1
(en)
|
2008-03-04 |
2009-09-24 |
University Of Iowa Research Foundation |
Methods for cloning ferrets and transgenic ferret models for diseases
|
WO2009151697A2
(en)
|
2008-03-14 |
2009-12-17 |
The Government Of United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compositions and processes relating to human bocavirus
|
WO2009146210A2
(en)
|
2008-04-17 |
2009-12-03 |
Blood Systems, Inc. |
New human parvovirus: bocavirus
|
US20110054247A1
(en)
|
2009-03-04 |
2011-03-03 |
University Of Iowa Research Foundation |
Methods for cloning ferrets and transgenic ferret models for diseases
|
WO2011097456A2
(en)
|
2010-02-05 |
2011-08-11 |
The University Of North Carolina At Chapel Hill |
Compositions and methods for enhanced parvovirus transduction
|
CA3174963A1
(en)
|
2013-04-08 |
2014-10-16 |
University Of Iowa Research Foundation |
Chimeric adeno-associated virus/ bocavirus parvovirus vector
|
EP3134113A4
(en)
|
2014-04-25 |
2017-11-29 |
University of Florida Research Foundation, Inc. |
Methods of permitting a subject to receive multiple doses of recombinant adeno-associated virus
|
EP3215602B1
(en)
|
2014-11-05 |
2019-12-25 |
The Research Institute at Nationwide Children's Hospital |
Methods and materials for producing recombinant viruses in eukaryotic microalgae
|
US11702672B2
(en)
|
2016-02-08 |
2023-07-18 |
University Of Iowa Research Foundation |
Methods to produce chimeric adeno-associated virus/bocavirus parvovirus
|
CA3016985C
(en)
|
2016-03-07 |
2023-07-04 |
University Of Iowa Research Foundation |
Aav-mediated expression using a synthetic promoter and enhancer
|
WO2017205739A1
(en)
|
2016-05-26 |
2017-11-30 |
University Of Iowa Research Foundation |
cis AND trans REQUIREMENTS FOR TERMINAL RESOLUTION OF HUMAN BOCAVIRUS 1
|
US11142775B2
(en)
|
2017-01-13 |
2021-10-12 |
University Of Iowa Research Foundation |
Bocaparvovirus small noncoding RNA and uses thereof
|
US20210255170A1
(en)
|
2018-03-13 |
2021-08-19 |
University Of Iowa Research Foundation |
Inductive regeneration of the airway by transcriptional factor modulation of glandular myoepithelial stem cells
|
KR20220044899A
(ko)
|
2019-04-15 |
2022-04-12 |
유니버시티 오브 아이오와 리써치 파운데이션 |
낭성 섬유증의 치료를 위한 조성물 및 방법
|
AU2020257182A1
(en)
|
2019-04-15 |
2021-12-09 |
Spirovant Sciences, Inc. |
Methods and compositions for transgene expression
|
EA202192819A1
(ru)
|
2020-01-29 |
2022-02-18 |
Юниверсити Оф Айова Рисерч Фаундейшн |
Способы и композиции для экспрессии трансгена
|
EA202192818A1
(ru)
|
2020-01-29 |
2022-03-03 |
Юниверсити Оф Айова Рисерч Фаундейшн |
Композиции и способы лечения муковисцидоза
|
WO2022006253A2
(en)
|
2020-06-30 |
2022-01-06 |
University Of Iowa Research Foundation |
Methods and compositions for administering recombinant viral vectors
|